TherapeutAix
TherapeutAix is a boutique life sciences consultancy founded in 2018 in Aachen, Germany, providing drug development strategy and translational science advisory to small and mid-sized biotechs, with specialization in fibrotic disease, inflammation, and orphan indications.
- Company typePrivate
- Founded2018
- HeadquartersAachen, Germany
- Headcount1–10
- GTM typeB2B
- OfferingServices
What TherapeutAix does
TherapeutAix is a life sciences consultancy founded in 2018 and headquartered in Aachen, Germany, structured as a private UG (haftungsbeschränkt) German entity. The firm provides drug development strategy and translational science advisory services, with particular specialization in fibrotic disease, inflammation, and orphan indications. Its client base consists primarily of small and mid-sized pre-clinical and clinical-stage biotechnology companies seeking external scientific expertise to guide portfolio and program decisions.
The consultancy's service portfolio spans drug development strategy, translational science, pharmacokinetic/pharmacodynamic (PK/PD) study design, and structured workshops for biotech clients. A distinctive commercial tactic is the offering of a complimentary initial project review, which the firm reports converts into paid engagements at a rate exceeding 90%. Its professional staff includes four directors whose collective industry experience exceeds 100 years, all of whom previously held roles within Grünenthal's Inflammation/Modulatory Units (IMU). Technical delivery is augmented by an ecosystem of seven named third-party partnerships covering analytical chemistry, bioanalytics, imaging, protein sciences, immunology, and biomarker capabilities.
The business operates on a professional services revenue model combining hourly consulting rates and fixed-fee project engagements. Customer references include MarraBio, ReNewVax, Inspira Pharmaceuticals, Sitryx, and Odin Therapeutics. The firm claims global reach, though engagement patterns indicate primary concentration across EMEA with selective US clients. Headcount sits between 1-10 employees, consistent with a boutique consultancy model, and the company has not raised external funding rounds.
TherapeutAix firmographics
Firmographics- Name
- TherapeutAix
- Legal name
- TherapeutAix UG (haftungsbeschränkt)
- Website
- https://therapeutaix.com
- Company type
- Private
- Founded year
- 2018
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- TherapeutAix is a boutique life sciences consultancy founded in 2018 in Aachen, Germany, providing drug development strategy and translational science advisory to small and mid-sized biotechs, with specialization in fibrotic disease, inflammation, and orphan indications.
- Ownership category
- akta.pro rank
TherapeutAix industry classification
Industry- Product category
- Pharmaceutical Consulting Services
- NAICS
- Other Scientific and Technical Consulting Services (54169)
- SIC
- Services-Management Consulting Services (8742)
- akta.pro primary industry
- Healthcare Outcomes & Real-World Evidence (RWE) Analytics (BPAHALAN)
- akta.pro secondary industries
- Regulatory Strategy & IND/NDA/BLA Submissions Support (HLAIALAH), Real-World Evidence (RWE) & HEOR for Development (HLAIALAI)
Keywords
Where TherapeutAix is headquartered
LocationHeadquarters
- HQ city
- Aachen
- HQ country
- Germany
- HQ region
- Europe
Offices1 record
Markets served
TherapeutAix business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Marketing or Sales, Operations, Others
Revenue model
- Consulting Services: Professional consulting services ranging from strategic advice to full project management and operationalisation. They offer flexible contracting models including hourly rates within agreed scope and fixed-fee projects. They quote fees for set packages of work where costs are fixed regardless of time taken.
- Workshop Facilitation: Bespoke workshop organization and moderation, including both client-specific workshops and crowd-funded consortium workshops where multiple companies share costs for precompetitive analysis.
- Free Initial Review: Free-of-charge initial project review offered to potential clients to assess projects and demonstrate value before formal engagement. This serves as a lead generation mechanism.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Pay-as-you-go | Free Initial Review |
| Usage-based | Pay-as-you-go | Hourly Consulting Rate |
| Outcome Based/ Performance | Multi-year contract | Fixed-Fee Project Package |
Go-to-market motion2 records
Distribution channels1 record
Marketing channels6 records
TherapeutAix product offering
Product offeringCore offering
TherapeutAix is a life sciences consultancy that combines subject matter expertise with a fully integrated R&D network to deliver practical, cost and time-efficient drug development solutions spanning preclinical, translational, and clinical phases through to proof-of-concept. The firm provides bespoke services ranging from advisory engagements to full project management and operationalisation, with a free initial project review offered to prospective clients and a three-stage methodology (Review, Strategy, Operations) underpinning engagements.
Product overview
TherapeutAix is a life sciences consultancy company offering a unified portfolio of drug development services. The core offering combines strategic consulting with a fully integrated R&D network to deliver practical solutions across the drug discovery continuum. Services include a complimentary initial project review, therapeutic area consulting (specializing in fibrotic diseases, cardiovascular, inflammation, immunology, neuroscience, respiratory, pain, tissue repair, and urology), translational science services, PK/PD design, bespoke workshop facilitation, and project strategy development. The company operates a three-stage approach: Review, Strategy, and Operations, ranging from advisory services to full project management and operationalisation.
Differentiator
Problem solved
Functional benefit
Products and services
- Drug Development Strategy Consulting Strategic consulting services combining subject matter expertise with a fully integrated R&D network to deliver practical, cost and time-efficient solutions for drug discovery projects from preclinical through clinical proof-of-concept.
- Free Initial Project Review A complimentary assessment of client projects allowing TherapeutAix to evaluate the project and demonstrate how they can work together, with over 90% of reviewed projects resulting in client engagements.
- Therapeutic Area Consulting Expert consulting in cardiovascular, inflammation, immunology, neuroscience, respiratory, pain, tissue repair, urology, and fibrotic diseases including NASH and IPF, with specialization in biomarkers and translational science.
- Translational Science Services Building translational strategies derived from understanding of target and disease biology with emphasis on models with human origin, including in vitro models with human cells or tissues, target engagement confirmation, and mechanistic animal models.
- PK/PD Design Services Design of optimal PK/PD packages that build confidence in target modulation and set foundations for successful clinical translation, with biomarker and disease endpoint assessments.
- Workshop Services Bespoke workshop formats for project teams ranging from data review to strategic discussions, including open innovation workshops and crowd-funded consortium workshops for precompetitive program aspects.
- Project Strategy Development Collaborative development of strategic objectives and design of future-proof evidence platforms that meet customer expectations, including optimal strategic positioning for developmental drugs.
Quantifiable outcome
- Over 90% client conversion rate from free initial review to paid engagement
- +1 more outcomes
Companies that use TherapeutAix
Customer profileNamed customers5 records
Segments5 records
Ideal customer profiles4 records
TherapeutAix technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
TherapeutAix partnerships and signals
Strategic signalPartnerships
Seven partnerships are on record, tiered core and supporting.
- Alderley AnalyticalcoreIndependent contract research organisation based at Alderley Park, Cheshire, UK, offering specialist bioanalytical services supporting drug development programs from discovery through clinical development. TherapeutAix began collaborating with them in 2020 after successfully helping a client overcome a challenging PK/PD situation. Collaboration includes dedicated project teams for integrated service delivery.
- Peak ProteinscoreContract research organisation based at Alderley Park, Cheshire, UK, providing tailor-made protein reagents, protein structure information using X-ray crystallography, and protein mass spectrometry. Collaboration began in 2020 after successfully helping a client overcome a PK/PD challenge. Dedicated project teams formed for integrated service delivery.
- ApconiXcoreIntegrated toxicology consultancy and ion channel laboratory specialising in nonclinical toxicology and safety science. Founded by former AstraZeneca colleagues, ApconiX provides drug discovery and development services to academic, biotech, and large pharmaceutical companies. TherapeutAix started working with them in 2018, referring clients requiring toxicology expertise while ApconiX refers clients needing broader project strategy support.
- BoydscorePharmaceutical consultancy working with pharma companies, biotechs, and spin-outs to support new medicine development. Specialises in orphan drug discovery, rare diseases, and offers clinical and regulatory insight. Partnership provides TherapeutAix clients with access to clinical and regulatory expertise and creative options for early clinical development strategy.
- Immunoconsulting LimitedsupportingConsulting firm assisting biopharmaceutical companies developing therapeutic strategies targeting immune system components across therapy areas. Led by Andrew Leishman with 20+ years of industry experience. Combined expertise enables high-quality analysis for immunology-focused projects, particularly immuno-oncology. Joint workshops have helped develop Target Product Profiles addressing clinical and partnering priorities.
- Nordic BiosciencecoreWorks in preclinical and clinical drug development, specialising in precision medicine using unique biomarker technologies to stratify patient populations and inform clinical trial design. Liaises with biotech and pharmaceutical clients to build pre-clinical disease understanding and develop biomarker-led strategies for early clinical proof of concept.
- OracleBiocoreHighly specialised image analysis CRO providing high precision, quantitative, digital image analysis services for pre-clinical and clinical research. Also offers integrated services covering ethical tissue procurement, histology, and immunohistochemistry. Has expertise in fibrosis, autoimmune disease, and oncology. Partnership enables TherapeutAix to access translational studies in animal models and human tissue.
Scale indicators4 records
Recent moves6 records
Expansion highlights4 records
TherapeutAix competitors and assessment
Company assessmentDirect peers
- Catenion: Berlin-based biopharma strategy consulting firm advising biotech and pharma clients on R&D portfolio strategy, project evaluation, and translational decision-making. Closely comparable boutique profile with similar senior-consultant-led model and drug development advisory focus.
- Health Advances: US-based strategy consulting firm focused exclusively on biopharma, supporting biotech and medtech clients with corporate strategy, product commercialization, and R&D portfolio decisions. Comparable boutique biopharma advisory serving similar customer profile with similar senior-consultant delivery model.
- Boyds: UK-based pharmaceutical consultancy supporting biotechs, spin-outs, and pharma companies with clinical and regulatory strategy in orphan and rare diseases. Directly comparable in size, therapeutic focus (specialist biotech advisory), and customer base, and is in fact a formal partner of TherapeutAix.
- Defined Health: US boutique biopharma strategic consulting firm advising emerging and established biopharma companies on therapeutic strategy, commercialization, and business development. Closely comparable in scale, therapeutic-area specialization, and biotech client focus.
- Alacrita: UK/US life sciences consulting firm providing strategic and operational support to biotech and pharma, including drug development strategy. Comparable boutique profile with similar drug development advisory scope.
- ClearView Healthcare Partners: US-based life sciences consulting firm providing strategic insights across therapeutic areas to pharma, biotech, and investors. Comparable in boutique scale, therapeutic strategy focus, and target customer base (biotech and pharma R&D leaders).
- Kineticos Life Sciences: US-based life sciences consulting firm advising biotech and pharma on strategy, M&A, and operational execution. Comparable boutique size with similar therapeutic-area strategy and biotech R&D advisory services.
Broad incumbents
- PharmaLex (Cencora): Large global life sciences consulting firm (now part of Cencora/Alliance Healthcare) offering regulatory, clinical, and drug development strategy services. Comparable in drug development advisory scope but broader in geographic footprint and service portfolio.
- Charles River Laboratories: Global CRO offering preclinical and clinical drug discovery and development services. Adjacent through its preclinical/translational and consulting capabilities, though much larger and broader in service scope than TherapeutAix's advisory-led model.
- IQVIA: Global clinical research services, commercial analytics, and consulting firm serving pharma and biotech across the full drug development lifecycle. Adjacent through its R&D strategy and consulting capabilities, though vastly larger and broader than TherapeutAix.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat3 records
Key risks6 records
Key highlights6 records
Customer concentration
TherapeutAix social profiles
Digital presenceTherapeutAix financial estimates
Financial estimateRevenue estimate
Valuation estimate
TherapeutAix leadership team
Management profileNumber of profiles
Profiles4 records
TherapeutAix funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
TherapeutAix M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about TherapeutAix
What does TherapeutAix do?
TherapeutAix is a life sciences consultancy that combines subject matter expertise with a fully integrated R&D network to deliver practical, cost and time-efficient drug development solutions spanning preclinical, translational, and clinical phases through to proof-of-concept. The firm provides bespoke services ranging from advisory engagements to full project management and operationalisation, with a free initial project review offered to prospective clients and a three-stage methodology (Review, Strategy, Operations) underpinning engagements.
Is TherapeutAix a public or private company?
TherapeutAix is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was TherapeutAix founded?
TherapeutAix was founded in 2018. It employs 1 to 10 people.
Where is TherapeutAix based?
TherapeutAix is headquartered in Aachen, Germany, in the Europe region.
How does TherapeutAix make money?
Three revenue lines are on record. Consulting Services are the primary driver. The others are workshop Facilitation and free Initial Review.
Who are TherapeutAix's main competitors?
Direct peers on record are Catenion, Health Advances, Boyds, Defined Health, Alacrita, ClearView Healthcare Partners and Kineticos Life Sciences. Broad incumbents are PharmaLex (Cencora), Charles River Laboratories and IQVIA.
Does TherapeutAix have an API?
No public API is recorded for TherapeutAix.
What industry is TherapeutAix in?
TherapeutAix's product category is Pharmaceutical Consulting Services. Its primary akta.pro industry code is BPAHALAN, Healthcare Outcomes & Real-World Evidence (RWE) Analytics, with a secondary code of HLAIALAH, Regulatory Strategy & IND/NDA/BLA Submissions Support. Its NAICS code is 54169 and its SIC code is 8742.